Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy

Area of Science:

• Neuroscience
• Metabolomics
• Proteomics

Background:

• Diabetic neuropathy (DN) is a common complication of diabetes.
• The exact molecular mechanisms driving the distal nerve damage in DN remain unclear.
• High glucose levels in the peripheral nervous system (PNS) are associated with DN pathogenesis.

Purpose of the Study:

• To investigate the system-wide molecular and metabolic changes in the PNS of a rodent model of diabetic neuropathy.
• To identify specific molecular alterations that contribute to the distal pathology observed in DN.
• To understand the spatial distribution of molecular dysfunction within the PNS during diabetes.

Main Methods:

• Integrated proteomics and metabolomics analysis.
• Comparison of sciatic nerve (SN), dorsal root ganglia (DRG), and trigeminal ganglia (TG) tissues.
• Utilized streptozotocin-induced diabetic and healthy control rat models.

Main Results:

• All analyzed tissues showed increased glucose and polyol pathway intermediates in diabetic rats.
• A significant upregulation of mitochondrial oxidative phosphorylation and altered lipid metabolism was observed specifically in the distal SN.
• These molecular changes were not detected in the DRG or TG cell bodies, indicating compartmentalized dysfunction.

Conclusions:

• The distal sciatic nerve exhibits unique metabolic perturbations, including enhanced mitochondrial activity and lipid metabolism changes, in diabetic neuropathy.
• These findings suggest a failure in energy homeostasis and potential oxidative stress localized to the distal axon and Schwann cells in the SN.
• The study highlights compartmentalized molecular dysfunction within the PNS, potentially explaining the distal-predominant pathology of diabetic neuropathy.